Celcuity (CELC) Receivables - Other (2019 - 2022)

Celcuity's (CELC) quarterly Receivables - Other came in at $95300.0 in Q2 2022, down 49.84% YoY from $190000.0 in Q2 2021, and down 50.63% on a QoQ basis from $193034.0 in Q1 2022.

Celcuity (CELC) Receivables - Other (2019 - 2022) Analysis & Trends

Celcuity (CELC) has 4 years of Receivables - Other data on file, last reported at $95300.0 in Q2 2022.

  • Quarterly Receivables - Other fell 49.84% year-over-year to $95300.0 in Q2 2022, while the trailing twelve-month figure through Jun 2022 was $95300.0 (down 49.84% YoY) and the FY2021 annual result came in at $298764.0, up 57.24% from the prior year.
  • Receivables - Other fell to $95300.0 in Q2 2022, from $193034.0 in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $356309.0 in Q3 2021 to a low of $95300.0 in Q2 2022.
  • A 4-year average of $206673.4 and a median of $190000.0 in 2019 frame the typical range for Receivables - Other.
  • Annual changes were most pronounced in 2021 — Receivables - Other jumped 87.53% — and 2022, when it tumbled 49.84%.
  • Tracing CELC's Receivables - Other over 4 years: stood at $190000.0 in 2019, then changed by 0.0% to $190000.0 in 2020, then surged by 57.24% to $298764.0 in 2021, then tumbled by 68.1% to $95300.0 in 2022.
  • The last three Receivables - Other figures came in at $95300.0 (Q2 2022), $193034.0 (Q1 2022), and $298764.0 (Q4 2021), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Celcuity 4.50 Bn 4.50 Bn -

Historic Data

Download Data
DateValue
Jun 30, 2022 95,300.00
Jun 30, 2022 95,300.00
Mar 31, 2022 193,034.00
Mar 31, 2022 193,034.00
Dec 31, 2021 298,764.00
Dec 31, 2021 298,764.00
Sep 30, 2021 356,309.00
Sep 30, 2021 356,309.00
Jun 30, 2021 190,000.00
Jun 30, 2021 190,000.00
Mar 31, 2021 190,000.00
Mar 31, 2021 190,000.00
Dec 31, 2020 190,000.00
Dec 31, 2020 190,000.00
Sep 30, 2020 190,000.00
Sep 30, 2020 190,000.00
Jun 30, 2020 190,000.00
Jun 30, 2020 190,000.00
Mar 31, 2020 190,000.00
Mar 31, 2020 190,000.00